✦ LIBER ✦

Prototype Model in Metastatic Castrate-Resistant Prostate Cancer (mCRPC): A Tool to Position New Treatments in the Patient Pathway?

✍ Scribed by Karcher, H.; Dinet, J.; Amzal, B.; Marteau, F.; Obrzut, G.; Pieniazek, I.; Brulais, S.; Gabriel, S.

Book ID: 122138801
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 57 KB
Volume: 16
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2013.08.1656

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

972 TREATMENT PRACTICE PATTERNS IN METAS

972 TREATMENT PRACTICE PATTERNS IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC) PATIENTS PRIOR TO RECEIVING SIPULEUCEL-T: DATA FROM PROCEED

✍ Cooperberg, Matthew; Sartor, Oliver; Pieczonka, Christopher; Concepcion, Raoul; 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 60 KB

Identification of the Treatment Pathway

Identification of the Treatment Pathway of Metastatic Castrate-Resistant Prostate Cancer in Scotland: A Chart Review

✍ Maman, K.; Khemiri, A.; Roïz, J.; Naidoo, S.; Baskin-Bey, E.; Holmstrom, S. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Response to Subsequent Docetaxel in a Pa

Response to Subsequent Docetaxel in a Patient Cohort With Metastatic Castration-Resistant Prostate Cancer After Abiraterone Acetate Treatment

✍ Aggarwal, Rahul; Harris, Anna; Formaker, Carl; Small, Eric J.; Molina, Arturo; G 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 344 KB

P112 Pre-treatment (pre-tx) neutrophil t

P112 Pre-treatment (pre-tx) neutrophil to lymphocyte ratio (NLR) in metastatic castration resistant prostate cancer (mCRPC) patients (pts) treated with ketoconazole (keto): Association with outcome and predictive model

✍ Keizman, D.; Ish-Shalom, M.; Maimon, N.; Gottfried, M.; Peer, A.; Neumann, A.; R 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

105 Exploratory analysis of the visceral

105 Exploratory analysis of the visceral disease patient subset in COU-AA-301, a phase III study of abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC)

✍ Suttmann, H.; Mulders, P.F.A.; Molina, A.; Goodman, O.B.; Flaig, T.W.; Li, J.; K 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 74 KB

S203 The impact of body mass index on th

S203 The impact of body mass index on the response to docetaxel treatment in patients with metastatic castration-resistant prostate cancer

✍ Culpan, M.; Yildirim, A.; Keskin, S.K.; Basok, E.K.; Canakci, C.; Arikan, O.; Pe 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 129 KB